HCA Healthcare Surges After Strong Q4 Earnings and Upgraded FY25 Guidance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 27 2026
0mins
Should l Buy CRWV?
Source: Benzinga
- Earnings Beat: HCA Healthcare reported an adjusted EPS of $8.01 for Q4, surpassing the analyst consensus of $7.43, indicating robust profitability and strong market demand.
- Stock Surge: Following the earnings report, HCA's shares jumped 9.5% to $517.00 on Tuesday, reflecting investor confidence in the company's future growth prospects.
- Upgraded Guidance: The company raised its FY25 guidance above estimates, signaling a positive outlook for business development that may attract more investor interest.
- Positive Market Reaction: HCA's favorable news boosted overall market confidence in the healthcare sector, potentially leading to further gains in related stocks.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CRWV?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CRWV
Wall Street analysts forecast CRWV stock price to rise
25 Analyst Rating
12 Buy
13 Hold
0 Sell
Moderate Buy
Current: 74.410
Low
68.00
Averages
123.23
High
180.00
Current: 74.410
Low
68.00
Averages
123.23
High
180.00
About CRWV
CoreWeave, Inc. is a cloud infrastructure technology company. The Company offers the CoreWeave Cloud Platform, which consists of software and cloud services that deliver the automation and efficiency needed to manage complex artificial intelligence (AI) infrastructure. Its CoreWeave Cloud Platform is an integrated solution that is purpose-built for running AI workloads such as model training and inference. Its solutions include infrastructure services, managed software services, and application software services. Its Infrastructure Services provide its customers with access to advanced graphics processing unit (GPU) and central processing unit (CPU) compute, highly performant networking, and storage. Its Managed Software Services include CKS, a flexible virtual private cloud and a bare metal service that runs kubernetes directly on high-performance servers. Its Application Software Services build on top of its infrastructure and managed software services, integrating additional tools.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
CoreWeave Expects Revenue of $12-$13 Billion for 2026
- Significant Revenue Growth: CoreWeave reported approximately $1.6 billion in sales for Q4 2025, marking a 110% year-over-year increase, with total revenue reaching $5.1 billion for the year, reflecting strong demand in the AI infrastructure market.
- Optimistic Future Outlook: Management anticipates revenue for 2026 to be between $12 billion and $13 billion, which at the midpoint represents about 144% growth, indicating confidence in future market demand.
- Increased Financial Pressure: With capital expenditures expected to double in 2026 to between $30 billion and $35 billion, CoreWeave's interest expenses exceeded $388 million in Q4 2025, highlighting the financial strain in the competitive AI infrastructure landscape.
- Stock Price Volatility Risk: CoreWeave's stock experienced a 24% drop in just a few days, falling from $101 to $76, reflecting market concerns over the future of AI infrastructure spending, necessitating cautious investor sentiment regarding its stock price fluctuations.
See More
CoreWeave's Stock Volatility Post-IPO Analysis
- IPO Performance and Stock Volatility: CoreWeave went public in March 2025 with an initial share price of $40, soaring to $187 within three months, but faced a steep decline post-lockup period, reflecting market concerns over AI infrastructure investment returns.
- Significant Sales Growth: The company reported approximately $1.6 billion in sales for Q4 2025, marking a 110% year-over-year increase, with total revenue rising 168% to $5.1 billion, and projected revenue for 2026 is expected to reach $12 billion to $13 billion, indicating strong market demand.
- Capital Expenditure Pressure: CoreWeave's interest expenses more than doubled year-over-year to $388 million in Q4 2025, with capital expenditures expected to rise to between $30 billion and $35 billion in 2026, highlighting the capital-intensive nature of its business.
- Investor Risk Advisory: Given the stock's volatility, CoreWeave is best suited for aggressive investors who should closely monitor its revenue conversion capabilities and interest expenses to mitigate risks associated with rapid market pullbacks.
See More
CoreWeave Faces Class Action for Securities Fraud
- Lawsuit Background: Bleichmar Fonti & Auld LLP has announced a class action lawsuit against CoreWeave and its executives, alleging securities fraud after significant stock drops due to concealed construction delays at data centers, resulting in investor losses.
- Stock Volatility: CoreWeave's stock plummeted 16% on November 11, 2025, dropping from $105.61 to $88.39 after the company lowered its revenue and operating income guidance, indicating severe market skepticism regarding its operational capabilities.
- Merger Failure Impact: On October 30, 2025, Core Scientific failed to secure enough shareholder votes to approve its merger with CoreWeave, causing a more than 6% drop in CoreWeave's stock price, reflecting investor disappointment in its future prospects.
- Legal Consequences: Investors must apply by March 13, 2026, to be appointed as lead plaintiffs, and if successful, this could significantly impact CoreWeave's operations and financial status, exacerbating the crisis of trust in the market.
See More
CoreWeave Faces Class Action Lawsuit Notification
- Class Action Initiation: Kahn Swick & Foti, LLC has notified investors that CoreWeave, Inc. is facing a class action lawsuit aimed at recovering losses for investors adversely affected by alleged securities fraud between March 28, 2025, and December 15, 2025, highlighting the serious legal risks the company faces.
- Allegations Overview: The lawsuit alleges that CoreWeave and certain executives failed to disclose material information during the class period, violating federal securities laws, including overstating the company's ability to meet customer demand and underestimating the risks associated with reliance on a single third-party data center supplier, which could materially impact revenue.
- Investor Action Recommendation: Affected CoreWeave investors have until March 13, 2026, to request to be appointed as lead plaintiff, although serving as lead plaintiff is not a prerequisite for recovery, which may prompt investors to act swiftly to protect their interests given the deadline.
- Law Firm Credentials: Kahn Swick & Foti, LLC is recognized as one of the nation's premier boutique securities litigation law firms, ranked among the top ten nationally based on total settlement value in the past year, demonstrating its expertise and influence in recovering investment losses from corporate fraud.
See More
CoreWeave Faces Class Action Lawsuit; Investors Encouraged to Contact Attorneys
- Class Action Initiated: Bragar Eagel & Squire has filed a class action lawsuit against CoreWeave in the U.S. District Court for New Jersey on behalf of investors who purchased securities between March 28, 2025, and December 15, 2025, indicating significant legal risks for the company.
- Allegations of False Statements: The lawsuit alleges that CoreWeave and its executives made false and misleading statements, failing to disclose the significant negative impact that reliance on a single third-party data center supplier could have on the company's revenue, potentially leading to investor losses.
- Investor Rights Protection: Affected investors must apply by March 13, 2026, to be appointed as lead plaintiffs in the lawsuit, highlighting the importance of protecting investor rights and the potential implications for future legal outcomes.
- Law Firm Background: Bragar Eagel & Squire is a nationally recognized law firm specializing in shareholder rights, focusing on securities and commercial litigation, underscoring its expertise and experience in advocating for investor rights.
See More
CoreWeave Securities Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased CoreWeave securities between March 28, 2025, and December 15, 2025, to apply as lead plaintiffs by March 13, 2026, to participate in the class action, as those who do not may miss out on potential compensation.
- Lawsuit Background: The lawsuit alleges that CoreWeave made false or misleading statements during the class period and failed to disclose the significant negative impact that reliance on a single third-party data center could have on its revenue, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and was ranked No. 1 by ISS Securities Class Action Services in 2017, recovering over $438 million for investors in 2019 alone, showcasing its success and resources in this field.
- Investor Guidance: Investors are advised to carefully select law firms with proven success in securities litigation, avoiding firms that merely act as intermediaries, to ensure effective legal representation and support in the class action.
See More
CoreWeave Expects Revenue of $12-$13 Billion for 2026
- Significant Revenue Growth: CoreWeave reported approximately $1.6 billion in sales for Q4 2025, marking a 110% year-over-year increase, with total revenue reaching $5.1 billion for the year, reflecting strong demand in the AI infrastructure market.
- Optimistic Future Outlook: Management anticipates revenue for 2026 to be between $12 billion and $13 billion, which at the midpoint represents about 144% growth, indicating confidence in future market demand.
- Increased Financial Pressure: With capital expenditures expected to double in 2026 to between $30 billion and $35 billion, CoreWeave's interest expenses exceeded $388 million in Q4 2025, highlighting the financial strain in the competitive AI infrastructure landscape.
- Stock Price Volatility Risk: CoreWeave's stock experienced a 24% drop in just a few days, falling from $101 to $76, reflecting market concerns over the future of AI infrastructure spending, necessitating cautious investor sentiment regarding its stock price fluctuations.
See More
CoreWeave's Stock Volatility Post-IPO Analysis
- IPO Performance and Stock Volatility: CoreWeave went public in March 2025 with an initial share price of $40, soaring to $187 within three months, but faced a steep decline post-lockup period, reflecting market concerns over AI infrastructure investment returns.
- Significant Sales Growth: The company reported approximately $1.6 billion in sales for Q4 2025, marking a 110% year-over-year increase, with total revenue rising 168% to $5.1 billion, and projected revenue for 2026 is expected to reach $12 billion to $13 billion, indicating strong market demand.
- Capital Expenditure Pressure: CoreWeave's interest expenses more than doubled year-over-year to $388 million in Q4 2025, with capital expenditures expected to rise to between $30 billion and $35 billion in 2026, highlighting the capital-intensive nature of its business.
- Investor Risk Advisory: Given the stock's volatility, CoreWeave is best suited for aggressive investors who should closely monitor its revenue conversion capabilities and interest expenses to mitigate risks associated with rapid market pullbacks.
See More
CoreWeave Faces Class Action for Securities Fraud
- Lawsuit Background: Bleichmar Fonti & Auld LLP has announced a class action lawsuit against CoreWeave and its executives, alleging securities fraud after significant stock drops due to concealed construction delays at data centers, resulting in investor losses.
- Stock Volatility: CoreWeave's stock plummeted 16% on November 11, 2025, dropping from $105.61 to $88.39 after the company lowered its revenue and operating income guidance, indicating severe market skepticism regarding its operational capabilities.
- Merger Failure Impact: On October 30, 2025, Core Scientific failed to secure enough shareholder votes to approve its merger with CoreWeave, causing a more than 6% drop in CoreWeave's stock price, reflecting investor disappointment in its future prospects.
- Legal Consequences: Investors must apply by March 13, 2026, to be appointed as lead plaintiffs, and if successful, this could significantly impact CoreWeave's operations and financial status, exacerbating the crisis of trust in the market.
See More
CoreWeave Faces Class Action Lawsuit Notification
- Class Action Initiation: Kahn Swick & Foti, LLC has notified investors that CoreWeave, Inc. is facing a class action lawsuit aimed at recovering losses for investors adversely affected by alleged securities fraud between March 28, 2025, and December 15, 2025, highlighting the serious legal risks the company faces.
- Allegations Overview: The lawsuit alleges that CoreWeave and certain executives failed to disclose material information during the class period, violating federal securities laws, including overstating the company's ability to meet customer demand and underestimating the risks associated with reliance on a single third-party data center supplier, which could materially impact revenue.
- Investor Action Recommendation: Affected CoreWeave investors have until March 13, 2026, to request to be appointed as lead plaintiff, although serving as lead plaintiff is not a prerequisite for recovery, which may prompt investors to act swiftly to protect their interests given the deadline.
- Law Firm Credentials: Kahn Swick & Foti, LLC is recognized as one of the nation's premier boutique securities litigation law firms, ranked among the top ten nationally based on total settlement value in the past year, demonstrating its expertise and influence in recovering investment losses from corporate fraud.
See More
CoreWeave Faces Class Action Lawsuit; Investors Encouraged to Contact Attorneys
- Class Action Initiated: Bragar Eagel & Squire has filed a class action lawsuit against CoreWeave in the U.S. District Court for New Jersey on behalf of investors who purchased securities between March 28, 2025, and December 15, 2025, indicating significant legal risks for the company.
- Allegations of False Statements: The lawsuit alleges that CoreWeave and its executives made false and misleading statements, failing to disclose the significant negative impact that reliance on a single third-party data center supplier could have on the company's revenue, potentially leading to investor losses.
- Investor Rights Protection: Affected investors must apply by March 13, 2026, to be appointed as lead plaintiffs in the lawsuit, highlighting the importance of protecting investor rights and the potential implications for future legal outcomes.
- Law Firm Background: Bragar Eagel & Squire is a nationally recognized law firm specializing in shareholder rights, focusing on securities and commercial litigation, underscoring its expertise and experience in advocating for investor rights.
See More
CoreWeave Securities Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased CoreWeave securities between March 28, 2025, and December 15, 2025, to apply as lead plaintiffs by March 13, 2026, to participate in the class action, as those who do not may miss out on potential compensation.
- Lawsuit Background: The lawsuit alleges that CoreWeave made false or misleading statements during the class period and failed to disclose the significant negative impact that reliance on a single third-party data center could have on its revenue, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and was ranked No. 1 by ISS Securities Class Action Services in 2017, recovering over $438 million for investors in 2019 alone, showcasing its success and resources in this field.
- Investor Guidance: Investors are advised to carefully select law firms with proven success in securities litigation, avoiding firms that merely act as intermediaries, to ensure effective legal representation and support in the class action.
See More
